nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A pharmacokinetic model for L-carnitine in patients receiving haemodialysis
|
Fornasini, Gianfranco |
|
2007 |
64 |
3 |
p. 335-345 |
artikel |
2 |
Authors' response: Homeopathy is safe and does not lack positive evidence in clinical trials/Scottish GPs use of Homeopathy
|
Ross, Sarah |
|
2007 |
64 |
3 |
p. 398-399 |
artikel |
3 |
Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards
|
Goldstein, Lee H. |
|
2007 |
64 |
3 |
p. 373-380 |
artikel |
4 |
CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment
|
Mehlotra, Rajeev K. |
|
2007 |
64 |
3 |
p. 391-395 |
artikel |
5 |
Development of oral anticoagulants
|
Ma, Qing |
|
2007 |
64 |
3 |
p. 263-265 |
artikel |
6 |
Editors' Report for 2006
|
|
|
2007 |
64 |
3 |
p. 253-254 |
artikel |
7 |
Effect of renal impairment on the pharmacokinetics of exenatide
|
Linnebjerg, Helle |
|
2007 |
64 |
3 |
p. 317-327 |
artikel |
8 |
Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole
|
Sostek, Mark B. |
|
2007 |
64 |
3 |
p. 386-390 |
artikel |
9 |
Erratum
|
|
|
2007 |
64 |
3 |
p. 401 |
artikel |
10 |
Foundation year 1 doctors and clinical pharmacology and therapeutics teaching. A retrospective view in light of experience
|
Tobaiqy, Mansour |
|
2007 |
64 |
3 |
p. 363-372 |
artikel |
11 |
Heart Rate Slowing by If Current Inhibition
|
|
|
2007 |
64 |
3 |
p. 400 |
artikel |
12 |
Homeopathy is safe and does not lack positive evidence in clinical trials
|
Mathie, Robert T. |
|
2007 |
64 |
3 |
p. 396-397 |
artikel |
13 |
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients
|
Solas, Caroline |
|
2007 |
64 |
3 |
p. 353-362 |
artikel |
14 |
Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size
|
Esposito-Festen, J. E. |
|
2007 |
64 |
3 |
p. 328-334 |
artikel |
15 |
Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath®) in patients with chronic lymphocytic leukaemia and its link to treatment response
|
Mould, D. R. |
|
2007 |
64 |
3 |
p. 278-291 |
artikel |
16 |
Primary care prescribing patterns in Ireland after the publication of large hypertension trials
|
Kabir, Zubair |
|
2007 |
64 |
3 |
p. 381-385 |
artikel |
17 |
Randomized exposure-controlled trials; impact of randomization and analysis strategies
|
Karlsson, Kristin E. |
|
2007 |
64 |
3 |
p. 266-277 |
artikel |
18 |
Scottish GPs use of homeopathy
|
Leckridge, Robert |
|
2007 |
64 |
3 |
p. 397-398 |
artikel |
19 |
Should we tolerate tolerability as an objective in early drug development?
|
Cohen, A. |
|
2007 |
64 |
3 |
p. 249-252 |
artikel |
20 |
Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women
|
Civelli, Maurizio |
|
2007 |
64 |
3 |
p. 304-316 |
artikel |
21 |
SLCO1B1 521T→C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients
|
Zhang, Wei |
|
2007 |
64 |
3 |
p. 346-352 |
artikel |
22 |
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
|
Stangier, Joachim |
|
2007 |
64 |
3 |
p. 292-303 |
artikel |
23 |
Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies
|
Bonovas, Stefanos |
|
2007 |
64 |
3 |
p. 255-262 |
artikel |